Maanasa Gowda

Statistics

Publications

Citations

546

H-Index

Active since

2020

Affiliations

University of Brescia(Current)

Novartis (Switzerland)

Fred Hutch Cancer Center

University Medical Center Freiburg

Bambino Gesù Children's Hospital

Maanasa Gowda is an author at University of Brescia specializing in pharmacotherapy, steroid-refractory graft-versus-host disease, and transplant immunology.

Publications per year

2020–2025

Publications

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

Robert Zeiser, Nicola Polverelli, Ron Ram et al. · New England Journal of Medicine · 2021 · 499 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study

Robert Zeiser, Nicola Polverelli, Ron Ram et al. · Blood · 2020 · 37 citations

Life Sciences, Clinical Sciences, Pharmacotherapy +12

Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study

Robert Zeiser, Domenico Russo, Ron Ram et al. · Journal of Clinical Oncology · 2025 · 10 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +12

1–3 of 3